The discrepancies observed between mice and humans regarding CCR2’s effects on cognitive function, i.e., CCR2 depletion causing cognitive decline, but higher CCR2 being associated with lower cognitive function, could be attributed to the differing demands for macrophage activation during cognitive decline, particularly in response to increased β-amyloid deposition, a hallmark of AD progression. Here, CCR2 is linked to Alzheimer disease.